WebMarie P Khoury 1 , Jean-Christophe Bourdon. Affiliation 1 CR-UK Cell Transformation Research Group, Inserm U858, Inserm-European Associated Laboratory, Centre of Oncology and Molecular Medicine, Ninewells Hospital, University of Dundee, Dundee, UK. PMID: 21779513 ... WebMar 1, 2024 · The company has announced the appointment of Christophe Bourdon as new Chief Executive Officer, effective April 1, 2024. Christophe Bourdon joins from Orphazyme A/S where he has held the position as CEO since April 2024, following global leadership roles in both Amgen and Alexion. Read more: LEO Pharma introduces a new …
Réussir Toute La Pharmacologie En 75 Fiches De Révision Et …
WebMar 1, 2024 · ORPHAZYME A/S: Orphazyme appoints Christophe Bourdon as Chief Executive Officer. March 1, 2024, 6:00 AM UTC. Share this article. Copied. Gift this article. Subscriber Benefit. WebMar 1, 2024 · Copenhagen, Denmark, March 1, 2024– Orphazyme A/S, a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today ... chetna jain cloudnine
LEO Pharma appoints Christophe Bourdon as new CEO
WebChristophe Bourdon (born 13 March 1970) is a French breaststroke swimmer. He competed in two events at the 1992 Summer Olympics. References ^ Evans, Hilary; Gjerde, Arild; Heijmans, Jeroen; Mallon, Bill; et al. "Christophe Bourdon Olympic Results". WebChristophe Bourdon's time at Danish meme stock Orphazyme, which has a rejected rare disease drug, will come to a head in March. Leo Pharma named Christophe Bourdon as its next CEO as the Danish ... WebDr. Jean-Christophe Bourdon earned his Ph.D. in cellular and molecular biology in 1997 at the Paris XI University, France. He is currently a senior lecturer at the School of Medicine at Dundee University. He was co-director of the Inserm- European Associated Laboratory (Toulouse University, France) in 2006-2010 and was awarded the prestigious fellowship … hunter psu 04